Published 2006 | Version v1
Publication

Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3.

Additional details

Created:
April 14, 2023
Modified:
November 30, 2023